These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3113153)

  • 1. Proliferative characteristics of acute nonlymphocytic leukemia in vivo.
    Raza A; Maheshwari Y; Ucar K; Mayers G; Preisler HD
    Acta Haematol; 1987; 77(3):140-5. PubMed ID: 3113153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for the in vivo analysis of proliferative characteristics of human leukemia cells in bone marrows.
    Nakamura S; Takeda Y; Kanno M; Yoshida T; Ohtake S; Kobayashi K; Okabe Y; Matsuda T
    Oncology; 1991; 48(4):285-9. PubMed ID: 1716352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the rate of DNA synthesis in myeloblasts from peripheral blood and bone marrows of patients with acute nonlymphocytic leukemia.
    Raza A; Yasin Z; Grande C
    Exp Cell Res; 1988 May; 176(1):13-9. PubMed ID: 3371420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in cell cycle characteristics among patients with acute nonlymphocytic leukemia.
    Raza A; Maheshwari Y; Preisler HD
    Blood; 1987 Jun; 69(6):1647-53. PubMed ID: 3555651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric analysis of proliferative characteristics of human leukemic cells in bone marrows in vivo using bromodeoxyuridine (BrdU) and its monoclonal antibody].
    Takeda Y; Kanno M; Nakamura S
    Nihon Rinsho; 1992 Oct; 50(10):2368-73. PubMed ID: 1447806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility and sensitivity of anti BrdU antibodies in assessing S-phase cells compared to autoradiography.
    Raza A; Ucar K; Bhayana R; Kempski M; Preisler HD
    Cell Biochem Funct; 1985 Apr; 3(2):149-53. PubMed ID: 3915232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia.
    Raza A; Ucar K; Preisler HD
    Cytometry; 1985 Nov; 6(6):633-40. PubMed ID: 3905302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical detection of S-phase cells in normal and neoplastic cervical epithelium by anti-BrdU monoclonal antibody.
    Fukuda K; Iwasaka T; Hachisuga T; Sugimori H; Tsugitomi H; Mutoh F
    Anal Quant Cytol Histol; 1990 Apr; 12(2):135-8. PubMed ID: 2350389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody.
    Veronese S; Gambacorta M; Falini B
    J Clin Pathol; 1989 Aug; 42(8):820-6. PubMed ID: 2475528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.
    Nagashima T; DeArmond SJ; Murovic J; Hoshino T
    Acta Neuropathol; 1985; 67(1-2):155-9. PubMed ID: 2992212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new method for studying cell cycle characteristics in ANLL using double-labeling with BrdU and 3HTdr.
    Raza A; Maheshwari Y; Yasin Z; Mandava N; Mayers G; Preisler HD
    Leuk Res; 1987; 11(12):1079-87. PubMed ID: 3320580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
    Risio M; Coverlizza S; Poccardi G; Candelaresi GL; Gaiola O
    Basic Appl Histochem; 1986; 30(4):469-77. PubMed ID: 3548696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
    Lee SS; Lee TS; Park JS; Cho EK; Chung CH
    J Korean Med Sci; 1989 Dec; 4(4):193-201. PubMed ID: 2639694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical demonstration of S phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma.
    Nemoto R; Uchida K; Shimazui T; Hattori K; Koiso K; Harada M
    J Urol; 1989 Feb; 141(2):337-40. PubMed ID: 2643726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for the analysis of tumor cell kinetics by flow cytometry].
    Kanno M; Takeda Y; Nakamura S
    Nihon Rinsho; 1992 Oct; 50(10):2333-7. PubMed ID: 1280304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-phase cell detection with a monoclonal antibody.
    Miltenburger HG; Sachse G; Schliermann M
    Dev Biol Stand; 1987; 66():91-9. PubMed ID: 3556275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
    Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
    Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of monoclonal antibodies directed against bromodeoxyuridine with pyrimidine bases, nucleosides, and DNA.
    Miller MR; Heyneman C; Walker S; Ulrich RG
    J Immunol; 1986 Mar; 136(5):1791-5. PubMed ID: 3950402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients.
    Miller MA; Mazewski CM; Yousuf N; Sheikh Y; White LM; Yanik GA; Hyams DM; Lampkin BC; Raza A
    J Histochem Cytochem; 1991 Apr; 39(4):407-12. PubMed ID: 2005370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proliferative activity of neurilemomas.
    Lee KS; Nagashima T; Cho KG; Mampalam TJ; Pitts LH; Hoshino T
    Surg Neurol; 1989 Dec; 32(6):427-33. PubMed ID: 2700052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.